A concise review of the cost-effectiveness of coronary heart disease prevention

被引:14
|
作者
Brown, AID
Garber, AM
机构
[1] Stanford Univ, Ctr Primary Care & Outcomes Res, Ctr Hlth Policy, Stanford, CA 94305 USA
[2] Univ Oxford, Dept Publ Hlth & Primary Care, Oxford OX3 7LF, England
[3] Univ Toronto, Dept Hlth Adm, Toronto, ON M5S 1A1, Canada
[4] Vet Affairs Palo Alto Hlth Care Syst, Stanford, CA USA
关键词
D O I
10.1016/S0025-7125(05)70219-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Coronary heart disease is one of the largest sources of morbidity, mortality, and health care expenditure in the United States. This article reviews a number of studies that estimate the cost per unit of health benefits associated with different primary and secondary prevention strategies for coronary heart disease. Although prevention does not provide a panacea for rising health care spending, many preventive strategies are cost-effective when compared to other common clinical interventions. Prevention should be incorporated into regular clinical practice.
引用
下载
收藏
页码:279 / +
页数:20
相关论文
共 50 条
  • [1] Cost-effectiveness of aspirin for the primary prevention of coronary heart disease
    Rodondi, Nicolas
    Moran, Andrew
    Coxson, Pamela G.
    Lightwood, James
    Williams, Lawrence W.
    Cornuz, Jacques
    Goldman, Lee
    CIRCULATION, 2006, 114 (18) : 827 - 827
  • [2] Comparative cost-effectiveness of interventions for the primary prevention of coronary heart disease
    Lim, SS
    Vos, TE
    Begg, S
    Liew, D
    Peeters, A
    McNeil, JJ
    CIRCULATION, 2002, 106 (19) : 758 - 759
  • [3] The cost-effectiveness of the SPHERE intervention for the secondary prevention of coronary heart disease
    Gillespie, Paddy
    O'Shea, Eamon
    Murphy, Andrew W.
    Byrne, Mary C.
    Byrne, Molly
    Smith, Susan M.
    Cupples, Margaret E.
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2010, 26 (03) : 263 - 271
  • [4] COST-EFFECTIVENESS OF ASPIRIN IN SECONDARY PREVENTION OF CORONARY HEART-DISEASE
    GASPOZ, JM
    GOLDMAN, P
    WILLIAMS, L
    WEINSTEIN, M
    GOLDMAN, L
    CIRCULATION, 1995, 92 (08) : 219 - 219
  • [5] Cost-effectiveness of statins for primary prevention of coronary heart disease in Japan
    Ikeda, Shunya
    Kobayashi, Makoto
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S225 - S226
  • [6] Cost-effectiveness of prevention of coronary disease in Germany
    Lauterbach, KW
    Gerber, A
    Klever-Deichert, G
    Stollenwerk, B
    ZEITSCHRIFT FUR KARDIOLOGIE, 2005, 94 : 100 - 104
  • [7] COST-EFFECTIVENESS OF ALTERNATIVE INTERVENTIONS FOR THE PREVENTION AND TREATMENT OF CORONARY HEART-DISEASE
    CROWLEY, S
    DUNT, D
    DAY, N
    AUSTRALIAN JOURNAL OF PUBLIC HEALTH, 1995, 19 (04): : 336 - 346
  • [8] Cost-effectiveness of sitostanols for the primary prevention of coronary heart disease in the Australian population
    Ashton, EL
    Lim, S
    McNeil, JJ
    Vos, T
    CIRCULATION, 2002, 106 (19) : 742 - 742
  • [9] COST-EFFECTIVENESS OF ANTIHYPERLIPEMIC THERAPY IN THE PREVENTION OF CORONARY HEART-DISEASE - THE CASE OF CHOLESTYRAMINE
    OSTER, G
    EPSTEIN, AM
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 258 (17): : 2381 - 2387
  • [10] Prevention of coronary heart disease with aspirin and clopidogrel: efficacy, safety, costs and cost-effectiveness
    Ho, WK
    Hankey, GJ
    Eikelboom, JW
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (03) : 493 - 503